|
GNG10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.729200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.902000E-02 |
| Normal-vs-Stage2 |
2.111600E-01 |
| Normal-vs-Stage3 |
5.343600E-01 |
| Normal-vs-Stage4 |
1.198790E-01 |
| Stage1-vs-Stage2 |
7.242000E-03 |
| Stage1-vs-Stage3 |
4.666100E-02 |
| Stage1-vs-Stage4 |
4.459900E-02 |
| Stage2-vs-Stage3 |
5.069400E-01 |
| Stage2-vs-Stage4 |
4.667600E-01 |
| Stage3-vs-Stage4 |
1.817360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.461900E-02 |
| Normal-vs-AfricanAmerican |
1.936160E-01 |
| Normal-vs-Asian |
8.876000E-01 |
| Caucasian-vs-AfricanAmerican |
8.864300E-03 |
| Caucasian-vs-Asian |
4.327600E-01 |
| AfricanAmerican-vs-Asian |
7.281400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.032100E-02 |
| Normal-vs-Female |
2.263900E-02 |
| Male-vs-Female |
4.06149999999661E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.328000E-01 |
| Normal-vs-Extreme_Weight |
1.686230E-01 |
| Normal-vs-Obese |
8.207000E-01 |
| Normal-vs-Extreme_Obese |
4.839700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.512460E-02 |
| Normal_Weight-vs-Obese |
2.072400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.431800E-02 |
| Extreme_Weight-vs-Obese |
2.892000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.907800E-01 |
| Obese-vs-Extreme_Obese |
2.196200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.434200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.851600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.304200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.697400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.288390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.838400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.302800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.015900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.510600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.222000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.432600E-01 |
| Normal-VS-Type2 PRCC |
2.682600E-01 |
| Normal-VS-KIRP CIMP |
2.044800E-03 |
| Normal-VS-Unclassified PRCC |
5.275000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.649200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.263450E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.194000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.398400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.588200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.541990E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.727200E-01 |
| Normal-vs-N1 |
1.280190E-01 |
| Normal-vs-N2 |
2.580000E-01 |
| N0-vs-N1 |
1.091050E-01 |
| N0-vs-N2 |
6.417900E-02 |
| N1-vs-N2 |
3.102000E-01 |
|
|
